May. 8, 2012—Vanderbilt researchers have boosted the efficiency of a novel source of white light called quantum dots more than tenfold, making them of potential interest for commercial applications.
Apr. 20, 2012—Antioxidants may be a beneficial treatment for an inherited genetic disorder.
Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.
Feb. 3, 2012—Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes.
Dec. 16, 2011—The Bill and Melinda Gates Foundation has given them $1 million to three Vanderbilt scientists to develop a point-of-care sample collection and preparation product that could bring advanced medical diagnostic testing to the third world.
Dec. 14, 2011—Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS).
Dec. 6, 2011—In the world of molecular biology, lipids haven’t gotten as much respect or attention as nucleic acids and proteins even though they play a number of essential biological functions. But now this chemically diverse class of molecules is emerging into the limelight. The development of new instruments that can efficiently identify fats, waxes, sterols, membrane...
Nov. 15, 2011—A team of Vanderbilt chemists have designed and successfully synthesized the largest artificial protein using a new approach that greatly expands scientists’ ability to create proteins unknown in nature.
Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.
Sep. 29, 2011—Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.
Sep. 26, 2011—Vanderbilt chemists have developed the first method that can rapidly and accurately map the surfaces of tiny particles that possess two chemically distinct faces. The findings have broad potential applications ranging from drug delivery to video displays.
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.